Serial Number | 97182740 |
Word Mark | ALMOND THERAPY: TARGETING THE AMYGDALA |
Filing Date | Tuesday, December 21, 2021 |
Status | 653 - SUSPENSION LETTER - MAILED |
Status Date | Wednesday, July 24, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Goods and Services | Provision of education in the nature of providing courses of instruction and training in the field of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes; provision of education in the nature of providing courses of instruction and training in the field of psychedelic medicines |
Goods and Services | Compilation of medical data for financial purposes relating to psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes |
Goods and Services | Compilation for business purposes and processing of medical data relating to psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes |
Goods and Services | Psychotherapy services; mental health therapy for the treatment of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes; provision of information to others in the field of mental health; clinical mental health counselling services |
NOT AVAILABLE | "THERAPY" |
Goods and Services | Medical and scientific research and development in the field of psychedelics; medical and scientific research in the field of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes; providing medical and scientific research information in the field of clinical trials; conducting clinical trials for others in the field of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes; laboratory research in the field of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes; providing temporary use of online, non-downloadable computer software for providing therapy services in the nature of scheduling and facilitating Internet-based patient and medical provider meetings to individuals in the field of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes; compilation of medical data for research purposes relating to psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes |
International Class | 035 - Advertising; business management; business administration; office functions. |
US Class Codes | 100, 101, 102 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, December 28, 2021 |
Primary Code | 035 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 036 - Insurance; financial affairs; monetary affairs; real estate affairs. |
US Class Codes | 100, 101, 102 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, August 24, 2022 |
Primary Code | 036 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
US Class Codes | 100, 101, 107 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, December 28, 2021 |
Primary Code | 041 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, December 28, 2021 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, December 28, 2021 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | PsiloTec Health Solutions Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Calgary, Alberta T2P4J8 CA |
Event Date | Event Description |
Friday, December 24, 2021 | NEW APPLICATION ENTERED |
Tuesday, December 28, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Friday, June 24, 2022 | ASSIGNED TO EXAMINER |
Tuesday, June 28, 2022 | NON-FINAL ACTION WRITTEN |
Tuesday, June 28, 2022 | NON-FINAL ACTION E-MAILED |
Tuesday, June 28, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Wednesday, August 24, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Wednesday, August 24, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, August 24, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Thursday, August 25, 2022 | SUSPENSION LETTER WRITTEN |
Thursday, August 25, 2022 | LETTER OF SUSPENSION E-MAILED |
Thursday, August 25, 2022 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
Thursday, February 23, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Thursday, February 23, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Thursday, February 23, 2023 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
Thursday, February 23, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Thursday, February 23, 2023 | SUSPENSION INQUIRY WRITTEN |
Thursday, February 23, 2023 | INQUIRY TO SUSPENSION E-MAILED |
Thursday, February 23, 2023 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
Tuesday, May 23, 2023 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
Sunday, October 22, 2023 | ASSIGNED TO LIE |
Monday, October 23, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Monday, October 23, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, October 23, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, October 24, 2023 | SUSPENSION LETTER WRITTEN |
Tuesday, October 24, 2023 | LETTER OF SUSPENSION E-MAILED |
Tuesday, October 24, 2023 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
Monday, April 22, 2024 | SUSPENSION INQUIRY WRITTEN |
Saturday, July 20, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Saturday, July 20, 2024 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
Wednesday, July 24, 2024 | SUSPENSION LETTER WRITTEN |
Wednesday, July 24, 2024 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
Wednesday, July 24, 2024 | LETTER OF SUSPENSION E-MAILED |
Monday, April 22, 2024 | INQUIRY TO SUSPENSION E-MAILED |
Monday, April 22, 2024 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
Saturday, July 20, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |